| First Author | Schlachterman A | Year | 2005 |
| Journal | J Thromb Haemost | Volume | 3 |
| Issue | 12 | Pages | 2730-7 |
| PubMed ID | 16359510 | Mgi Jnum | J:328560 |
| Mgi Id | MGI:7335144 | Doi | 10.1111/j.1538-7836.2005.01639.x |
| Citation | Schlachterman A, et al. (2005) Factor V Leiden improves in vivo hemostasis in murine hemophilia models. J Thromb Haemost 3(12):2730-7 |
| abstractText | The role of factor V Leiden (FVL) as a modifier of the severe hemophilia phenotype is still unclear. We used mice with hemophilia A or B crossed with FVL to elucidate in vivo parameters of hemostasis. Real-time thrombus formation in the microcirculation was monitored by deposition of labeled platelets upon laser-induced endothelial injury using widefield microscopy in living animals. No thrombi formed in hemophilic A or B mice following vascular injuries. However, hemophilic mice, either heterozygous or homozygous for FVL, formed clots at all injured sites. Injection of purified activated FV into hemophilic A or B mice could mimic the in vivo effect of FVL. In contrast to these responses to a laser injury in a microvascular bed, FVL did not provide sustained hemostasis following damage of large vessels in a ferric chloride carotid artery injury model, despite of the improvement of clotting times and high circulating thrombin levels. Together these data provide evidence that FVL has the ability to improve the hemophilia A or B phenotype, but this effect is principally evident at the microcirculation level following a particular vascular injury. Our observations may partly explain the heterogeneous clinical evidence of the beneficial role of FVL in hemophilia. |
